Differences in brain BA receptor gene expression (including receptors involved in BA homeostasis) in AD compared to CON.

AD, Alzheimer disease; BA, bile acid; CHRM2, Cholinergic Receptor Muscarinic 2; CHRM3, Cholinergic Receptor Muscarinic 3; CON, control; FDR, false discovery rate (Benjamini–Hochberg) corrected p-value; FPR1, Formyl Peptide Receptor 1; GPBAR1, G Protein-Coupled Bile Acid Receptor 1; HNF4A, Hepatocyte Nuclear Factor 4 Alpha; KDR, Kinase Insert Domain Receptor; NR1H2, Nuclear Receptor Subfamily 1 Group H Member 2; NR1H3, Nuclear Receptor Subfamily 1 Group H Member 3; NR1H4, Nuclear Receptor Subfamily 1 Group H Member 4; NR1I2, Nuclear Receptor Subfamily 1 Group I Member 2; NR1I3, Nuclear Receptor Subfamily 1 Group I Member 3; NR3C1, Nuclear Receptor Subfamily 3 Group C Member 1; NR5A2, Nuclear Receptor Subfamily 5 Group A Member 2; PPARA, Peroxisome Proliferator Activated Receptor Alpha; PPARD, Peroxisome Proliferator Activated Receptor Delta; PPARG, Peroxisome Proliferator Activated Receptor Gamma; pval: p-value; RARA, Retinoic Acid Receptor Alpha; RXRA, Retinoid X Receptor Alpha; RXRB, Retinoid X Receptor Beta; RXRG, Retinoid X Receptor Gamma; VDR, Vitamin D Receptor.
(XLSX)